These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 3084167

  • 1. Five years' experience with levonorgestrel-releasing IUDs.
    Luukkainen T, Allonen H, Haukkamaa M, Lähteenmäki P, Nilsson CG, Toivonen J.
    Contraception; 1986 Feb; 33(2):139-48. PubMed ID: 3084167
    [Abstract] [Full Text] [Related]

  • 2. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.
    Sivin I, el Mahgoub S, McCarthy T, Mishell DR, Shoupe D, Alvarez F, Brache V, Jimenez E, Diaz J, Faundes A.
    Contraception; 1990 Oct; 42(4):361-78. PubMed ID: 2124179
    [Abstract] [Full Text] [Related]

  • 3. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
    Sivin I, Stern J, Diaz J, Diaz MM, Faundes A, el Mahgoub S, Diaz S, Pavez M, Coutinho E, Mattos CE.
    Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
    Luukkainen T, Toivonen J.
    Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T.
    Andersson K, Batar I, Rybo G.
    Contraception; 1992 Dec; 46(6):575-84. PubMed ID: 1493717
    [Abstract] [Full Text] [Related]

  • 15. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J, Heikinheimo O, Lähteenmäki P, Suhonen S.
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [Abstract] [Full Text] [Related]

  • 16. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
    Sturridge F, Guillebaud J.
    Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Intrauterine steroid contraceptives.
    Scholten PC, Christaens GC, Haspels AA.
    Wien Med Wochenschr; 1987 Nov 15; 137(20-21):479-83. PubMed ID: 3131966
    [Abstract] [Full Text] [Related]

  • 20. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
    Heinemann K, Reed S, Moehner S, Minh TD.
    Contraception; 2015 Apr 15; 91(4):280-3. PubMed ID: 25601350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.